Inspection Record

North American Institute of Medicinal Plants — Health Canada Inspection Findings

Health CanadaInspected 2026-02-09 7 findingsComputer system validationLaboratory and QC controlsEquipment and facilityDeviation, CAPA, and investigationMaterial and supplier controlValidation and qualification

View the regulator's official source The source document is always the basis for judgement.

Findings

1Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The usage logs for the equipment used for significant processing and/or testing operations were inadequate. A preventative maintenance system had not been established for the equipment used in significant processing and/or testing operations

2Laboratory and QC controls

The establishment and/or the maintenance of a data governance plan was inadequate. The quality control department did not undertake all of the required activities.

3Equipment and facility

The handling of standard operating procedures for good manufacturing practices was inadequate. The maintenance of records was inadequate.

4Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. The maintenance of records was inadequate.

5Material and supplier control

The handling and/or storage of samples was inadequate for raw materials, drugs being processed, bulk drugs, and/or finished products. The temperature and/or humidity control was inadequate.

6Validation and qualification

Validation studies were not conducted in keeping with the predefined protocols.

7Equipment and facility

The ongoing training of personnel was inadequate. The training of personnel before new or revised standard operating procedures were implemented was inadequate. The maintenance of personnel records was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2026-02-09. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

North American Institute of Medicinal Plants company profile — full history Health Canada documents, 2026 Go to Findings search